News
Market and company headlines
INNVAll
Loading
08:00Oct 201 Story
06:00Sep 271 Story
04:00Sep 261 Story
00:00-05:00Sep 232 Stories
InnovAge, Voyager Technologies And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. futures edged higher; InnovAge fell 9.4% after a 10M-share offering. Jaguar Health, Voyager Technologies and other stocks also dropped premarket.
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REIT led gainers, while Jaguar Health and Biomea fell.
20:00-23:00Sep 222 Stories
InnovAge (INNV) Shares Tumble 9% After Hours: Here's Why
InnovAge shares fall 9% after hours following pricing of a 10 million share secondary offering Tuesday.
InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders
DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock by investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe (together, the “Sell
16:00Sep 221 Story
03:00Sep 161 Story
07:00-21:00Sep 102 Stories
InnovAge (INNV) Reaches a 9.6% Adjusted EBITDA Margin. Can the PACE Recovery Last?
InnovAge Holding Corp. (NASDAQ:INNV) reported fiscal 2026 revenue of $989.7 million on September 8, up 15.9%. Company-defined non-GAAP adjusted EBITDA reached $94.6 million, versus $34.5 million a year earlier. The measure adjusts net income or loss for net interest, investment income, taxes, depreciation and amortization, stock compensation, losses on cost and equity-method investments, and specified […]
InnovAge: Operational Momentum Is Winning Out Over The Risks
InnovAge Holding Corp. stays a Buy as revenue, margins, and cash flow improve; see FY2026 results, FY2027 guidance, key risks, & outlook. Click for an INNV update.
04:00Sep 101 Story
17:00-19:00Sep 92 Stories
InnovAge (INNV) Q4 2026 Earnings Call Transcript
Adjusted EBITDA surged 174% despite litigation accruals impacting net income.
InnovAge Holding Corp. (INNV) Presents at Wells Fargo 21st Annual Healthcare Conference - Slideshow
2026-09-09. The following slide deck was published by InnovAge Holding Corp.